Search
for
Sort by
Research 331–360 of 1000+
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- <i>Eclipta prostrata</i> promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Efficacy and safety of topical 5% minoxidil in treatment of androgenetic alopecia
- 5α-Reductases In Human Physiology: an Unfolding Story
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- 5α-Reduced glucocorticoids: a story of natural selection
- Medical therapy for frontal fibrosing alopecia: A review and clinical approach
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Urinary steroids in women with androgenic alopecia
- Post-finasteride syndrome
- Serum 3α-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris
- Plants as potential active components in treatment of androgenetic alopecia
- Testosterone metabolite nonessential for androgen effects
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Acute, diffuse and total alopecia
- A randomized, blinded, three-arm, multicenter trial comparing the efficacy and safety of fluconazole given once daily for 3 or 6 weeks with griseofulvin given once daily for 6 weeks in pediatric patients with tinea capitis
- Alopecia areata in the United States: Outpatient utilization and common prescribing patterns
- Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
- ς<sub>1</sub>Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward